Page last updated: 2024-08-25

adriamycinol and Lymphoma, Non-Hodgkin

adriamycinol has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fernández de Gatta, MD; García, MJ; Hernández-Rivas, JM; Martín, A; Pérez-Blanco, JS; Santos-Buelga, D	1

Other Studies

1 other study(ies) available for adriamycinol and Lymphoma, Non-Hodgkin

Article	Year
Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma. British journal of clinical pharmacology, 2016, Volume: 82, Issue:6 Topics: Antibiotics, Antineoplastic; Area Under Curve; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Models, Biological; Randomized Controlled Trials as Topic	2016

Article

Year

Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma.

British journal of clinical pharmacology, 2016, Volume: 82, Issue:6

Topics: Antibiotics, Antineoplastic; Area Under Curve; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Models, Biological; Randomized Controlled Trials as Topic

2016